Scientist Solutions: International Life Science Community By Scientists For Scientists
    
Home » Societies » The Biotech Research Society of India Forum

The Biotech Research Society of India Forum

Thanks to our sponsors who make this site possible
Welcome Members and guests. Our Forum is brought to you through our partnership with Scientist Solu-
tions.com which manages these pages to promote the free exchange of useful scientific information. We
encourage you to dive in and join the conversation!

How do I use this forum?
Registered members can create new topics and reply to topics from other users. To learn more about s-
uccessful posting in the forums Click Here. Subscribing to Society Sub-forums will keep you informed
and involved.
Disclaimer - The The Biotech Research Society of India Society supports the free exchange of scientific information, but is not responsible or liable for comments made in public forums such as this one. Topics and posts deemed unsuitable will be moderated and removed.


The Biotech Research Society of India Subforums

RSS Feed
Sub-forumsTopics  Replies  ViewsLast Post

Strategies to Identify Drug Targets/Biomarkers

Biomarkers
22 23 36084

Urgent Dilution problem! Please hel ...


by Saluferkimo
May 21, 2015, 15:24 PM

Target Validation Techniques

Target Validation Techniques
9 9 24565

WHY LIPIDS NOT PAID MORE ATTENTION?


by skarthikumar
Nov 09, 2012, 11:02 AM

Pharmacokinetics

Extent and rate of absorption, distribution, metabolism and excretion ( ADME)
18 46 53379

piclamilast


by Debbie Reed Bietz
Jun 25, 2012, 11:25 AM

Bioprocessing/Scale Up and Isolation

Fermentation, cell culture, expression, and recovery
22 27 37577

isolating dna from spotted on filte ...


by Pippuri
May 04, 2015, 16:26 PM

Good Manufacturing/Validation Practice (GMP/GVP)

Control and management
24 51 51898

Performance Qualification (PQ) of L ...


by Eibhor
Aug 17, 2015, 21:01 PM

Equipment

Pharmacology equipment
18 49 47290

How to choose your system Fiber opt ...


by Idealphotonics
Oct 05, 2015, 6:41 AM

Assay Development & Protocols

Also, remember to visit the protocols tab on the homepage toolbar
48 46 59921

Xanthine Oxidase Inhibitory Assay


by Paye
Feb 27, 2012, 20:34 PM



Society Overview

The aims & objectives of the Biotech Research Society [BRSI] are:
  • To promote the R&D in biotechnology in India
  • To bring interaction between the academic institutes and the biotech industries, interact with the industries and help them in resolving their problems, as well make them aware with the latest developments in the biotech sector
  • To provide and arrange the training in biotechnology, dissemination of biotech knowledge through the organization of the lectures, seminars and symposia on the scientific programmes and societal missions.

Contact Society Forum Organizer
Society Organizer: Ashok Pandey

Click here to
Become a member & join our
community (It's easy & free)
Already a member? Please log in
User Name  
Password  
Forget Password?
News Feeds from
BioTech News
Biotech news continually updated from thousands of sources around the net.

" The CEOs of athletic wear manufacturer Under Armour and pharmaceutical company Merck resigned Monday from the White House's American Manufacturing Council " with the Merck withdrawal drawing a quick and angry Twitter outburst from President Donald Trump. Merck CEO Kenneth Frazier cited the president's failure to explicitly rebuke the white nationalists who marched in Charlottesville, Virginia, over the weekend.

A study in mice from the O'Donnell Brain Institute and UC Irvine shows that eating at abnormal times disrupts the biological clock of the skin, including the daytime potency of an enzyme that protects against the sun's harmful ultraviolet radiation. Although further research is needed, the finding indicates that people who eat late at night may be more vulnerable to sunburn and longer-term effects such as skin aging and skin cancer, said Dr. Joseph S. Takahashi , Chairman of Neuroscience at UT Southwestern Medical Center's Peter O'Donnell Jr. Brain Institute .

A Windham neighbor of President Donald Trump's former campaign manager Corey Lewandowski alleges the Republican operative threatened to use his political clout and connections to make his life a... Trinity High of Manchester will not field a varsity football team in Division II this fall and the school has already announced it plans to compete in ... (more)

Since 2016, two master developers have pulled out of the 15-acre project, which city officials are billing as an up-and-coming hub for the biotech industry and other high-tech companies. After the resignation of the most recent developer, Winn Development, in February, the city issued a request for proposals for a replacement.

Merus Labs International and The Medicines are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings. 19.7% of Merus Labs International shares are owned by institutional investors.

The global aerospace lightnin... )--The "Global Pipe Coating Market 2017-2021" report has been added to Research and Markets' offering. The global pipe coating market to grow at a CAGR of 4.41% during the per... CORRECTING and REPLACING AES Announces Tender Offer for Up to $217 Million of Its 8.00% Senior Notes due 2020 )--The "Principal Amount Outstanding" in the financial table of release should read: $445,465,000 .

US Bancorp DE cut its stake in shares of Trinity Biotech PLC by 67.4% during the second quarter, Holdings Channel reports. The fund owned 114,980 shares of the company's stock after selling 237,204 shares during the period.

The iShares Nasdaq Biotechnology Index has tacked on a healthy gain of around 15% so far this year, without any help from Celldex Therapeutics, Inc. Is the pessimism justified, or has the market underestimated the potential value drivers within these companies' drug development pipelines? Let's take a cool-headed look at each to see if there's something for long-term value investors to get excited about. This biotech took a few steps back earlier this summer, when one of its clinical-stage candidates, varlilumab, generated less than thrilling results for 21 patients with advanced-stage colorectal and ovarian cancer when given in combination with Opdivo from Bristol-Myers Squibb .

Merck & Co Inc Chief Executive Kenneth Frazier resigned from U.S. President Donald Trump's American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism. A gathering of hundreds of white nationalists in Virginia took a deadly turn on Saturday when a car plowed into a group of counter-protesters and killed at least one person.

MERCK & Co Inc Chief Executive Kenneth Frazier resigned from US President Donald Trump's American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism. A gathering of hundreds of white nationalists in Virginia took a deadly turn on Saturday when a car ploughed into a group of counter-protesters and killed at least one person.

Merck CEO Kenneth Frazier is seated at President Donald Trump's right during a White House meeting in late January with representatives of the Pharmaceutical Research and Manufacturers of America trade group. Merck & Co.

TOO HIGH: The 84-year-old was performing at the USANA Amphitheater in the Utah city, which is more than 4,200 feet above sea level, on Sunday night when he appeared to be having breathing problems Country music star Willie Nelson cut his gig short on Sunday night after struggling with the altitude in Salt Lake City. The 84-year-old was performing at the USANA Amphitheater in the Utah city, which is more than 4,200 feet above sea level, on Sunday night when he appeared to be having breathing problems.

The biotech industry is often unloved, there is a tremendous amount of volatility and most people would rather pick up a technology or blue-chip stock. Simply looking at the end figures is enough to spark an interest; a mean growth of 483% in just under 10 years.

Asset Dedication LLC increased its position in shares of Johnson & Johnson by 1.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,093 shares of the company's stock after buying an additional 174 shares during the period.

Press coverage about Intec Pharma has trended somewhat positive on Sunday, according to Accern. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources.

Media coverage about ImmunoGen has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time.

That's one. Then there's... well, actually, that's it. J&J's acquisition of Actelion is the only truly big biotech buyout year to date, unless you also want to include Japanese drugmaker Takeda 's $5.2 billion deal to buy Ariad in the first quarter.

Thank You to Our Sponsor